Stay updated on Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial

Sign up to get notified when there's something new on the Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A 403 Forbidden message appears in the page body, with a Home link, rather than clinical study details.
    Difference
    0.5%
    Check dated 2026-10-03T14:04:49.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error and navigation, hiding the study record details that were previously listed (e.g., title, conditions, inclusion/exclusion criteria, locations, and contacts).
    Difference
    19%
    Check dated 2026-09-19T19:20:58.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The page now displays the latest system revision tag (v3.6.6) replacing the previous v3.6.5. This indicates a software update and does not alter the study details, eligibility criteria, or results on the page.
    Difference
    0.1%
    Check dated 2026-08-29T18:55:36.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.4 to v3.6.5, indicating a small internal update to the page or CMS. No user-visible content changes are expected.
    Difference
    0.1%
    Check dated 2026-08-08T10:45:25.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.6.3 to v3.6.4, indicating a minor update to the page’s documentation/display. No study content appears to be changed.
    Difference
    0.1%
    Check dated 2026-07-25T06:27:47.000Z thumbnail image
  7. Check
    96 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.2 to v3.6.3, signaling a new minor update to the record. This maintenance update does not alter study details or eligibility information.
    Difference
    0.1%
    Check dated 2026-07-03T21:45:52.000Z thumbnail image

Stay in the know with updates to Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial page.